DADC
VCYT icon

D.A. Davidson & Co’s Veracyte VCYT Stock Holding History

D.A. Davidson & Co’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,210
Closed -$688K – 1505
2025
Q1 		$688K Sell
23,210
-144
-0.6% -$5.49K 0.01% 901
2024
Q4 		$925K Buy
+23,354
New +$884K 0.01% 804
2017
Q4 		– Sell
-24,800
Closed -$217K – 1137
2017
Q3 		$217K Hold
24,800
– – ﹤0.01% 986
2017
Q2 		$206K Hold
24,800
– – ﹤0.01% 944
2017
Q1 		$227K Buy
+24,800
New +$203K 0.01% 888

Other funds holding VCYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.A. Davidson & Co's VCYT Position: Q2 2025 in Review

D.A. Davidson & Co sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 23,210 shares — an estimated $688K sold.

D.A. Davidson & Co first reported a position in VCYT in Q1 2017 and held it in 5 quarters. The position peaked at $925K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

  • D.A. Davidson & Co reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
  • D.A. Davidson & Co sold 23,210 Veracyte shares in Q2 2025, an estimated $688K.
  • D.A. Davidson & Co first reported a position in Veracyte in Q1 2017 and held it in 5 quarters.
  • D.A. Davidson & Co's Veracyte position peaked at $925K in Q4 2024.
  • 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on D.A. Davidson & Co's 13F filing for Q2 2025, filed 30 Jul 2025.